Literature DB >> 17131786

Introduction of an in-house PCR for routine identification of M. tuberculosis in a low-income country.

J Muhumuza1, B B Asiimwe, S Kayes, R Mugyenyi, C Whalen, R D Mugerwa, H Boom, K D Eisenach, M L Joloba.   

Abstract

SETTING: National Tuberculosis (TB) Treatment Centre, Makerere University Medical School and Joint Clinical Research Centre, Kampala, Uganda.
OBJECTIVE: To evaluate the introduction of a polymerase chain reaction (PCR) based assay for identification of the Mycobacterium tuberculosis complex (MTC) into routine practice.
DESIGN: Routine diagnostic specimens were processed and inoculated into Bactec 12B vials and monitored daily. At a growth index (GI) > or =10, 0.5 ml of the 12B broth was removed and assayed with PCR. The same 12B vial was analyzed using the Bactec NAP method at GI > or =500. Vials at various levels of GI were included. Recurrent cost and time required to perform PCR and NAP were compared.
RESULTS: Initially, 71 specimens were analyzed; of these, 68 were NAP-positive while 69 were PCR-positive for MTC. PCR resulted in a 75% reduction in cost for a single test compared with Bactec NAP. PCR has been successfully incorporated into routine practice, and 432 samples have been analyzed. In addition, isolates from solid media were also well identified by PCR. With PCR, more samples can be analyzed at a time, it is faster and is less labor intensive.
CONCLUSION: PCR is a reliable and cheaper alternative for the identification of MTC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17131786

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  18 in total

1.  Handheld point-of-care cerebrospinal fluid lactate testing predicts bacterial meningitis in Uganda.

Authors:  Albert Majwala; Rebecca Burke; William Patterson; Relana Pinkerton; Conrad Muzoora; L Anthony Wilson; Christopher C Moore
Journal:  Am J Trop Med Hyg       Date:  2012-12-12       Impact factor: 2.345

2.  Respiratory cryptosporidiosis in HIV-seronegative children in Uganda: potential for respiratory transmission.

Authors:  Siobhan M Mor; James K Tumwine; Grace Ndeezi; Maheswari G Srinivasan; Deogratias H Kaddu-Mulindwa; Saul Tzipori; Jeffrey K Griffiths
Journal:  Clin Infect Dis       Date:  2010-05-15       Impact factor: 9.079

3.  Prevalence of pulmonary TB and spoligotype pattern of Mycobacterium tuberculosis among TB suspects in a rural community in Southwest Ethiopia.

Authors:  Amare Deribew; Gemeda Abebe; Ludwig Apers; Alemseged Abdissa; Fetene Deribe; Kifle Woldemichael; Chali Jira; Markos Tesfaye; Jafar Shiffa; Abraham Aseffa; Mesele Bezabih; Tadiye Abeje; Robert Colebunders
Journal:  BMC Infect Dis       Date:  2012-03-13       Impact factor: 3.090

4.  Detection of multiple strains of Mycobacterium tuberculosis using MIRU-VNTR in patients with pulmonary tuberculosis in Kampala, Uganda.

Authors:  Katherine R Dickman; Lydia Nabyonga; David P Kateete; Fred A Katabazi; Benon B Asiimwe; Harriet K Mayanja; Alphonse Okwera; Christopher Whalen; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2010-12-10       Impact factor: 3.090

5.  The T2 Mycobacterium tuberculosis genotype, predominant in Kampala, Uganda, shows negative correlation with antituberculosis drug resistance.

Authors:  Deus Lukoye; Fred A Katabazi; Kenneth Musisi; David P Kateete; Benon B Asiimwe; Moses Okee; Moses L Joloba; Frank G J Cobelens
Journal:  Antimicrob Agents Chemother       Date:  2014-04-28       Impact factor: 5.191

6.  Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda.

Authors:  Beth Temple; Irene Ayakaka; Sam Ogwang; Helen Nabanjja; Susan Kayes; Susan Nakubulwa; William Worodria; Jonathan Levin; Moses Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Peter G Smith; Roy D Mugerwa; Jerrold J Ellner; Edward C Jones-López
Journal:  Clin Infect Dis       Date:  2008-11-01       Impact factor: 9.079

7.  Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study.

Authors:  Edward C Jones-López; Irene Ayakaka; Jonathan Levin; Nancy Reilly; Francis Mumbowa; Scott Dryden-Peterson; Grace Nyakoojo; Kevin Fennelly; Beth Temple; Susan Nakubulwa; Moses L Joloba; Alphonse Okwera; Kathleen D Eisenach; Ruth McNerney; Alison M Elliott; Jerrold J Ellner; Peter G Smith; Roy D Mugerwa
Journal:  PLoS Med       Date:  2011-03-15       Impact factor: 11.069

8.  Determination of circulating Mycobacterium tuberculosis strains and transmission patterns among pulmonary TB patients in Kawempe municipality, Uganda, using MIRU-VNTR.

Authors:  Lydia Nabyonga; David P Kateete; Fred A Katabazi; Paul R Odong; Christopher C Whalen; Katherine R Dickman; Joloba L Moses
Journal:  BMC Res Notes       Date:  2011-08-11

9.  Comparison of rapid tests for detection of rifampicin-resistant Mycobacterium tuberculosis in Kampala, Uganda.

Authors:  Sam Ogwang; Benon B Asiimwe; Hamidou Traore; Francis Mumbowa; Alphonse Okwera; Kathleen D Eisenach; Susan Kayes; Edward C Jones-López; Ruth McNerney; William Worodria; Irene Ayakaka; Roy D Mugerwa; Peter G Smith; Jerrold Ellner; Moses L Joloba
Journal:  BMC Infect Dis       Date:  2009-08-26       Impact factor: 3.090

10.  Evaluation of in-house PCR for diagnosis of smear-negative pulmonary tuberculosis in Kampala, Uganda.

Authors:  Lydia Nakiyingi; David P Kateete; Ponsiano Ocama; William Worodria; Joseph B Sempa; Benon B Asiimwe; Fred A Katabazi; Achilles Katamba; Laurence Huang; Moses L Joloba; Harriet Mayanja-Kizza
Journal:  BMC Res Notes       Date:  2012-09-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.